Divalproex Long-Acting Tablets and Omalizumab Subcutaneous
Determining the interaction of Divalproex Long-Acting Tablets and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Long-Acting Tablets-Ombitasvir, Paritaprevir, and Ritonavir
- Divalproex Long-Acting Tablets-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Divalproex Long-Acting Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Divalproex Long-Acting Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Divalproex Long-Acting Tablets-Omeclamox-Pak
- Divalproex Long-Acting Tablets-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Divalproex sodium
- Omalizumab Subcutaneous-Divalproex Sprinkle
- Omalizumab Subcutaneous-Divalproex Sprinkle Capsules
- Omalizumab Subcutaneous-Divigel
- Omalizumab Subcutaneous-Divigel 0.75 mg/packet for use on skin
- Omalizumab Subcutaneous-Divigel Transdermal